title: Relationship between herd size and annual prevalence of and primary antimicrobial treatments for common diseases on dairy operations in the United States.
abstract: Dairy operations in states representing 86% of the United States' national dairy herd were surveyed regarding the occurrence of common dairy diseases or disorders (digestive, respiratory, gastrointestinal, lameness, mastitis, navel infection) in specified production groups (weaned heifers, unweaned heifers, adult cows), and the most common antimicrobial preparation used to treat these conditions. Within disease and production group, disease frequency and characteristics of primary antimicrobial (drug class, availability, spectrum of activity, extra-label usage, withdrawal times) were compared among herd sizes (30-99, 100-499, and >/=500 cows) using chi-square or t-tests that accounted for the sampling design. The most common diseases were mastitis and lameness in cows, and gastrointestinal disease in unweaned calves, affecting 16, 11, and 15% of the target populations, respectively. Herd-level disease prevalence tended to increase as herd size increased, whereas within-herd prevalence tended to decrease as herd size increased. Broad-spectrum antimicrobials were selected as primary treatments by a majority of operations for nearly all diseases surveyed. When treating gastrointestinal disease, navel infection, or reproductive disorders, a majority of operations selected primary treatments not specifically labeled for that condition. Selection of over-the-counter preparations tended to decrease as herd size increased, whereas selection of broad-spectrum preparations tended to increase with herd size.
authors.affiliation: Animal Population Health Institute, Campus Delivery 1678, Colorado State University, Fort Collins, CO 80523-1678, USA. Ashley.Hill@colostate.edu
authors.forename: Ashley E
authors.initials: AE
authors.lastname: Hill
authors.forename: Alice L
authors.initials: AL
authors.lastname: Green
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Wagner
authors.forename: David A
authors.initials: DA
authors.lastname: Dargatz
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000453:epidemiology; D003430:Cross-Sectional Studies; D003612:Dairying / Q000379:methods*; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary; D007794:Lameness, Animal / Q000188:drug therapy / Q000453:epidemiology; D008414:Mastitis, Bovine / Q000188:drug therapy / Q000453:epidemiology; D011156:Population Density; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D014886:Weaning
chemical_list: D000900:Anti-Bacterial Agents